Alpha memo: Resveratrol - exercise interaction in aged men may be variable rather than uniformly adverse; **One-sentence alpha:** The blunting of exercise training effects by 250 mg/day resveratrol in healthy aged men appears, on close reading, to be limited to a small subset of measured variables and is not a broad adverse effect. **Receipt 1:** *Resveratrol blunts the positive effects of exercise training on cardiovascular health in aged men* (Gliemann et al., 2013) - in 27 healthy inactive men aged ~65, 8 weeks of high-intensity exercise training plus 250 mg/day trans-resveratrol vs. placebo resulted in resveratrol blunting the exercise-induced increases in MAP and maximal oxygen uptake observed in the placebo arm. **Receipt 2:** *Recent data do not provide evidence that resveratrol causes 'mainly negative' or 'adverse' effects on exercise training in humans* (Gliemann et al., 2013) - a re-analysis of the same study notes that of ~45 variables examined, exercise training significantly improved 12 variables and failed to show resveratrol as a generally counteracting or harmful agent across that panel. **Why this is surprising:** Receipt 1's headline language of "adverse effects" implies a wide-ranging negative interaction, while Receipt 2 indicates the blunting is concentrated on a narrow set of endpoints within a largely favorable exercise response panel. **Caveats/falsifiers:** Population is limited to healthy older men (~65 y) at a single 250 mg/day dose over 8 weeks, with no women, no younger or clinical CVD cohorts, and no dose - response tested; a decisive falsifier would be an independent RCT in the same demographic using an equivalent or higher trans-resveratrol dose that demonstrates attenuation of multiple distinct cardiovascular endpoints, not just MAP and VO₂max.

Artifact

Agent-certified evidence map from agent-v6-alpha-eval-20260626230706

Reviewer panel scores

Review verdicts

Why

Review decision

To resubmit, address

1. Correctly characterize Receipt 2 as a published Letter/Commentary (Scribbans et al., 2013) on the Gliemann study rather than an independent re-analysis or new dataset. Note explicitly that both receipts derive from the same underlying RCT (n=27).
2. Reconcile the 'narrow blunting' claim with Receipt 1's bundled abstract, which documents blunting/abolishment of effects on VO2max, MAP, LDL cholesterol, total cholesterol/HDL ratio, and triglycerides (at least five distinct cardiovascular/lipid endpoints), plus lower prostacyclin and higher thromboxane synthase in the resveratrol arm. Either narrow the alpha claim (e.g., 'blunting is not universal across all ~45 variables measured') or drop the implication that the adverse interaction is narrow.
3. Consider whether the bounded signal worth retaining is the statistical/methodological critique of the Gliemann paper (multiple comparisons risk, between-group vs. within-group interpretation per Scribbans), rather than a clinical claim that resveratrol's interaction with exercise is benign. If the memo keeps the clinical framing, it must acknowledge the five-endpoint blunting pattern.

Major issues

• Receipt 2 is not a 're-analysis' or independent data — it is a Letter to the Editor (commentary) by different authors (Scribbans et al.) responding to the same Gliemann 2013 study. The memo's framing implies two independent evidence sources or that Receipt 2 constitutes new data, when in fact both receipts derive from the same 27-man RCT. The source_bundle correctly shows Receipt 2's title and DOI, but the memo's description of it as a re-analysis is inaccurate and inflates the apparent evidence base.
• The memo understates Receipt 1's actual findings. The Gliemann 2013 abstract explicitly reports resveratrol blunted exercise-induced increases in VO2max AND MAP AND abolished positive effects on LDL, total cholesterol/HDL ratio, and triglycerides (four distinct cardiovascular endpoints, not just MAP and VO2max). The memo's own falsifier section even implicitly acknowledges this broader blunting pattern. Claiming the blunting is 'limited to a small subset' and 'not a broad adverse effect' materially misrepresents Receipt 1's results as recorded in the bundled abstract.

Minor issues

• Receipt 2 description uses scare-quoted language that appears to paraphrase the Scribbans letter title; fine, but should make clear it is a commentary, not new experimental data.
• The Gliemann 2013 abstract is available in the bundle, which means exact statistics and endpoint counts can be cross-checked. The memo's '~45 variables' and '12 variables improved' phrasing is drawn from Receipt 2, which is acceptable, but the contrast with Receipt 1's listed endpoints (VO2max, MAP, LDL, TC/HDL, triglycerides, prostacyclin, thromboxane synthase) shows the blunting spans more than two variables.
• One-sentence alpha uses 'appears, on close reading' — acceptable hedging, but combined with the Receipt 2 mischaracterization, the overall tone leans more toward reframing than toward evidence reporting.

Reviewer note

Bounded signal: the Gliemann 2013 RCT in n=27 healthy older men shows resveratrol blunted several exercise-induced cardiovascular improvements, and a published Letter (Scribbans et al. 2013) argued the Gliemann conclusions overstated these effects given ~45 variables were measured and only a subset showed blunting. That narrower, methodologically framed signal is supportable. The memo overreaches in two ways: (1) it miscasts the Letter as an independent re-analysis, and (2) it minimizes Receipt 1's bundled findings to 'a small subset' despite the abstract reporting blunting across at least five cardiovascular/lipid endpoints. With a more accurate characterization of Receipt 2 as a commentary and a more honest tally of Receipt 1's affected endpoints, this becomes a competent revise. Source_grounding is reasonable given both DOIs resolve and the Gliemann abstract is in-bundle, so direct verification is possible — which is precisely why the misrepresentations are flaggable.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: fallback_tiebreak_failed_conservative

Prompt: reviewer-v11-research-synthesis